KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

CRISPR Therapeutics AG (CRSP) Return on Invested Capital (2016 - 2025)

Historic Return on Invested Capital for CRISPR Therapeutics AG (CRSP) over the last 10 years, with Q4 2025 value amounting to 0.35%.

  • CRISPR Therapeutics AG's Return on Invested Capital fell 1000.0% to 0.35% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.35%, marking a year-over-year decrease of 1000.0%. This contributed to the annual value of 0.35% for FY2025, which is 1000.0% down from last year.
  • Per CRISPR Therapeutics AG's latest filing, its Return on Invested Capital stood at 0.35% for Q4 2025, which was down 1000.0% from 0.32% recorded in Q3 2025.
  • In the past 5 years, CRISPR Therapeutics AG's Return on Invested Capital ranged from a high of 0.2% in Q2 2021 and a low of 0.35% during Q4 2022
  • In the last 5 years, CRISPR Therapeutics AG's Return on Invested Capital had a median value of 0.24% in 2023 and averaged 0.17%.
  • Per our database at Business Quant, CRISPR Therapeutics AG's Return on Invested Capital soared by 3900bps in 2021 and then plummeted by -5000bps in 2022.
  • CRISPR Therapeutics AG's Return on Invested Capital (Quarter) stood at 0.15% in 2021, then plummeted by -333bps to 0.35% in 2022, then surged by 64bps to 0.13% in 2023, then tumbled by -94bps to 0.24% in 2024, then plummeted by -43bps to 0.35% in 2025.
  • Its last three reported values are 0.35% in Q4 2025, 0.32% for Q3 2025, and 0.31% during Q2 2025.